Edition:
United States

Hua Han Health Industry Holdings Ltd (0587.HK)

0587.HK on Hong Kong Stock

0.53HKD
--
Change (% chg)

-- (--)
Prev Close
HK$0.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
0
52-wk High
HK$0.53
52-wk Low
HK$0.53

Summary

Name Age Since Current Position

Peter Zhang

52 Executive Chairman of the Board

Jie Deng

49 Chief Executive Officer, Executive Director

Hong Ming Yang

49 Chairman - Guilin Pavay Gene Pharmaceutical Company Limited

Chang Fa Yao

48 Chairman - Guiyang De Chang Xiang Pharmaceutical Company Limited

Shu Guang Bian

58 2017 Deputy General Manager, Executive Director

Ming Chun Wong

32 2009 Financial Controller, Company Secretary

Yi Niu

41 2017 Executive Director, Director of Human Resources Affairs

Chong Ke Zhou

52 2010 Executive Director

Li Gui Dai

44 2011 Chief Inspector - Marketing function of Guizhou Factorr Bio-Technology Company Ltd.

Zhong Ming Wei

45 Vice General Manager - Guilin Pavay Gene Pharmaceutical Company Limited

Bing Sheng Zhang

37 Chief Investment Supervisor

Jin Yi Zhang

51 2011 General Manager - Guizhou Hanfang Medicine Manufacture Co., Ltd.

Kun Mou Zhang

50 2008 General Manager - Guizhou Factorr Bio-Technology Company Limited

Ming Hong Zhang

49 Chief Engineer - Guizhou Factorr Bio-Technology Co., Ltd.

Shou Xue Zhang

44 2011 Factory Manager - Guizhou Hanfang Medicine Manufacture Co., Ltd.

Bang Yin Zou

38 2011 Deputy General Manager - Guizhou Hanfang Medicine Manufacture Co., Ltd.

Sien Hao Tarn

2006 Non-Executive Director

Chun Kit Chan

34 2017 Non-Executive Independent Director

Shu Guang Lin

65 2015 Independent Non-Executive Director

Xin Zhou

53 2015 Independent Non-Executive Director

Biographies

Name Description

Peter Zhang

Mr. Zhang Peter Y. is Executive Chairman of the Board of Hua Han Bio-Pharmaceutical Holdings Limited. Mr. Zhang graduated from Guiyang Teacher Training College in 1982 with Bachelor Degree in Chemistry. Mr. Zhang has been appointed as a standing member of the Fifth Chinese People’s Political Consultative Conference in Yunyan District of Guiyang City. In 1999, he was awarded a postgraduate certificate from the Nankai University majoring in enterprise management. Mr. Zhang was awarded the title of 1998-2002 Guiyang City Young and Middle-aged Technological Leader in 2000. Mr. Zhang is in charge of group's overall strategic planning. With more than 20 years of experience in corporate financial planning, Mr. Zhang is responsible for the Group’s strategic management, financial planning and control. Mr. Zhang is a controlling Shareholder and a director of Bull’s-Eye Limited, a controlling Shareholder of the Company.

Jie Deng

Mr. Deng Jie is Chief Executive Officer and Executive Director of Hua Han Bio-Pharmaceutical Holdings Limited. Mr. Deng graduated from Peking University in 1985 with a Bachelor Degree in Law. He was appointed as a member of the Eighth and the Ninth Chinese People’s Political Consultative Conference in Guizhou since 1998. In 1999, he was awarded a postgraduate certificate from the Nankai University majoring in enterprise management. He has over 20 years of experience in corporate management, and is responsible for the Group’s strategic management and operation management. Over the past 20 years or so, Mr. Deng has been actively involved in establishing the Group’s sales network throughout the PRC and is experienced in training the Group’s sales and marketing team. Mr. Deng is a director of Bull’s-Eye Limited, a controlling shareholder of the Company.

Hong Ming Yang

Mr. Yang Hong Ming is Chairman of Guilin Pavay Gene Pharmaceutical Company Limited, a subsidiary of Hua Han Bio-Pharmaceutical Holdings Limited. Mr. Yang graduated from the Department of International Trade, University of International Business and Economics in 1985 with a Bachelor Degree in Economics. After graduation, Mr. Yang worked in the China Resources Group and acquired the title of senior economist and was appointed as the standing committee member of the First and Second Chinese People’s Political Consultative Conference in Guilin. Mr. Yang joined the Group in 2008 and is responsible for the strategic planning management and external relations of Guilin Pavay Gene Pharmaceutical Co., Ltd.

Chang Fa Yao

Mr. Yao Chang Fa is Chairman of Guiyang De Chang Xiang Pharmaceutical Company Limited, a subsidiary of Hua Han Bio-Pharmaceutical Holdings Limited. Mr. Yao graduated from Guiyang Chinese Medical College in 1987. He acquired the professional qualification of principal Chinese medical practitioner in 1996, and graduated from Beijing University of Aeronautics and Astronautics in postgraduate studies in business administration in 2004. Mr. Yao joined the Group in 1992 and is responsible for the operation management functions for Guiyang De Chang Xiang Pharmaceutical Company Limited.

Shu Guang Bian

Mr. Bian Shu Guang is Deputy General Manager, Executive Director of the Company. He was an executive Director of the Company for the period from 2007 to 2009. Mr. Bian graduated from Guiyang Teacher Training College in 1984 with a bachelor’s degree in Chinese. He obtained a certificate in master of business administration in pharmaceutical from the Postgraduate School of Renmin University of China in 2004. Mr. Bian joined the Group in 1993 and has long been serving in capacity of operation and management of the Group’s traditional Chinese medicine business and has been a member of the executive board of the Guizhou Pharmaceutical Society since 2000. Mr. Bian is familiar with the pharmaceutical market in the PRC and the operation and management of a pharmaceutical enterprise. With his outstanding background in the industry, he is mainly responsible for stem cell and immunocyte storage and application of the Group.

Ming Chun Wong

Mr. Wong Ming Chun is Financial Controller and Company Secretary of Hua Han Bio Pharmaceutical Holdings Limited. He is responsible for the Group’s financial management and internal auditing. He is a member of The Association of Chartered Certified Accountants, an associate member of the Hong Kong Institute of Certified Public Accountants, a member of each of the Hong Kong Institute of Chartered Secretaries and the Institute of Chartered Secretaries and Administrators and a CFA charterholder of the CFA Institute. Mr. Wong graduated from The Hong Kong University of Science and Technology with a Bachelor Degree in Business Administration (major in Accounting). Mr. Wong has over 9 years of experience in auditing, accounting and financial management. He joined the Group in 2008.

Yi Niu

Ms. Niu Yi is Executive Director, Director of Human Resources Affairs of the Company. She is the director of human resources affairs of the Group and has acquired the title of senior economist and the professional qualification of senior human resources manager. Ms. Niu graduated from Guizhou Normal University with a bachelor’s degree in literature in 1996, and obtained a master degree in business administration from Guizhou University in 2007. Also, she was awarded the Global Career Development Facilitator (GCDF) Certification by the Consulting and Education Certification Center of the USA in 2009. Ms. Niu joined the Group in 1996, and is currently responsible for human resources, administration management and corporate culture management of the Group.

Chong Ke Zhou

Mr. Zhou Chong Ke is Executive Director of Hua Han Bio-Pharmaceutical Holdings Limited since 7 April 2010. Mr. Zhou graduated from Guiyang Medical University in 1983 with a Bachelor Degree in Medicine. He also has a postgraduate degree certificate in Psychiatry from West China University of Medical Sciences. He joined the Group in 2007 and is responsible for the sales-integrated operations of business for the pharmaceutical enterprises under the Group. Prior to joining the Group, he has assumed senior positions in certain pharmaceutical companies in PRC. With his excellent industry background, apart from primarily responsible for the sales-integrated operations of business for the pharmaceutical enterprises under the Group currently, Mr. Zhou is also responsible to assist the Chief Executive Officer the operation of external merger and acquisition projects and maintains the close relationships among the Group and its strategic partners (including the research institutes).

Li Gui Dai

Mr. Dai Li Gui is Chief Inspector of Marketing function of Guizhou Factorr Bio-Technology Company Ltd., a subsidiary of Hua Han Bio-Pharmaceutical Holdings Limited. He is responsible for the marketing functions of biological medicine. Mr. Dai graduated from Department of Medicine, Guiyang Medical College in 1992 with a Bachelor Degree in Medicine. In 2002, he attended a parttime Master Degree course in regard to Oncology and doctor’s degree courses in regard to Oncology and Medical Consultation at the Western China University of Medical Science. He is currently studying a doctorate degree course. Before joining the Group in 2000, Mr. Dai served the Pulmonary Hospital of Guiyang City as a clinician for 8 years.

Zhong Ming Wei

Mr. Wei Zhong Ming is Vice General Manager of Guilin Pavay Gene Pharmaceutical Company Limited, a subsidiary of Hua Han Bio-Pharmaceutical Holdings Limited. Mr. Wei graduated from Department of Chemistry, Nankai University in 1990 with a Bachelor Degree in Chemistry. After graduation, Mr. Wei worked in Guilin No. 3 Pharmaceutical Factory, Guilin Medical University and Beijing Pilot Test Base of Guilin Pavay Gene Pharmaceutical Co., Ltd. He is one of the major researchers and testers for the two State category one new medicines of Guilin Pavay Gene Pharmaceutical Co., Ltd. Mr. Wei joined the Group in 2008 and is responsible for the production technology and quality control of Guilin Pavay Gene Pharmaceutical Co., Ltd.

Bing Sheng Zhang

Mr. Zhang Bing Sheng is Chief Investment Supervisor of Hua Han Bio-Pharmaceutical Holdings Limited. He joined the Group in May 2007. Mr. Zhang graduated from Hubei Medical College majoring in Clinical Medication. He worked in Shenzhen Medical Enhancement Import and Export Company Limited and Shenzhen Qing Hua Yuan Xing Bio-pharmaceutical Technology Company Limited etc.. He has extensive experience in the academic promotion of market specialization as well as the marketing and operation of prescription drugs. Especially, Mr. Zhang achieved outstanding results in areas such as marketing, sales planning and expert network construction. He has solid personal network in Chinese Medical Association and its subordinate professional institutions and the large and medium scale local general hospitals.

Jin Yi Zhang

Mr. Zhang Jin Yi is General Manager of Guizhou Hanfang Medicine Manufacture Company Ltd., a subsidiary of Hua Han Bio-Pharmaceutical Holdings Limited. Mr. Zhang graduated from Northwestern Polytechnical University in 1984 with a Bachelor Degree in Engineering and acquired the title of senior engineer. He joined the Group in 2004 and is responsible for the production management functions for Guizhou Hanfang Medicine Manufacture Co., Ltd.

Kun Mou Zhang

Mr. Zhang Kun Mou is General Manager of Guizhou Factorr Bio-Technology Company Limited, a subsidiary of Hua Han Bio-Pharmaceutical Holdings Limited. Mr. Zhang graduated from Harbin Engineering University (formerly known as Harbin Vessel Engineering College) and obtained a Bachelor Degree in Engineering in 1984. In 1989, he graduated from Shanghai Donghua University) ( formerly known as China Textile University) with a Master Degree in Engineering and served as a senior engineer. Mr. Zhang joined the Group in 2000 and is responsible for managing the production facilities of Guizhou Factorr Bio-Technology Co., Ltd. Mr. Zhang is an executive director of Magic Holdings International Limited, a public company listed on the Main Board of the Stock Exchange.

Ming Hong Zhang

Mr. Zhang Ming Hong is Chief Engineer of Guizhou Factorr Bio-Technology Co., Ltd., subsidiary of Hua Han Bio-Pharmaceutical Holdings Limited. Mr. Zhang graduated from Department of Pharmacy, West China University of Medical Science in 1986 and obtained a Bachelor Degree in Medicine. He joined the Group in 2007 and is responsible for the research and development of drugs and GMP implementation works of Guizhou Factorr Bio-Technology Co., Ltd.

Shou Xue Zhang

Mr. Zhang Shou Xue is Factory Manager of Guizhou Hanfang Medicine Manufacture Co., Ltd., a subsidiary of Hua Han Bio Pharmaceutical Holdings Limited. He graduated from Guiyang Chinese Medical College in 1989. Mr. Zhang acquired the qualifications of chief pharmacist and licensed pharmacist, and has experience in medicine production and management with comprehensive capabilities of total quality management. He was honored as the advanced individual on technological renovation of Guiyang City in 2009. Mr. Zhang joined in the Group in 2001, and is responsible for assisting the General Manager in production management of Guizhou Hanfang Medicine Manufacture Co., Ltd.

Bang Yin Zou

Mr. Zou Bang Yin is Deputy General Manager of Guizhou Hanfang Medicine Manufacture Co., Ltd., a subsidiary of Hua Han Bio-Pharmaceutical Holdings Limited. Mr. Zou being in charge of technological service, product development and quality control functions of the company. Mr. Zou graduated from Beijing Institute of Technology majoring Biochemical Engineering in 1999, and obtained a Master Degree in Medicine from Guiyang Medical College with a qualification certificate of national licensed pharmacist in 2002. He joined the Group in 1999.

Sien Hao Tarn

Mr. Tarn Sien Hao is Non-Executive Director of Hua Han Bio-Pharmaceutical Holdings Limited. Mr. Tarn holds a Bachelor of Science Degree from Columbia University, a Bachelor of Arts Degree from the State University of New York and a Master of Business Administration Degree from the University of Dubuque. He is the Group General Manager of Haw Par Corporation Limited, a public company listed on the Singapore Exchange Securities Trading Limited. He joined the Group in 2006.

Chun Kit Chan

Mr. Chan Chun Kit is Non-Executive Independent Director of the Company. He has been the chief financial officer and the joint company secretary of China Flexible Packaging Holdings Limited (‘‘China Flexible’’) since 2011. China Flexible is listed on the main board of Singapore Exchange Securities Trading Limited. Mr. Chan is in charge of the overall control of China Flexible’s finance department and is responsible for overseeing its financial management function, corporate finance activities, corporate governance and practices. Mr. Chan also has several years audit experience. From 2007 to 2011, he worked in an international audit firm and was responsible for the financial audit for a broad range of engagements including annual statutory audit, equity financing, merger and acquisition activities and initial public offering projects. He is a member of the Hong Kong Institute of Certified Public Accountants, the Hong Kong Institute of Chartered Secretaries and the Institute of Chartered Secretaries and Administrators. He graduated from the Hong Kong Polytechnic University with a master degree in corporate governance in 2014 and a bachelor’s degree in accountancy in 2007.

Shu Guang Lin

Professor Lin Shu Guang is Independent Non-Executive Director of the Company. He currently holds positions such as the vice chairman of Chinese Medical Doctor Association, the chairman of Guangdong Medical Doctor Association, the honorary president of Guangdong General Hospital, a fellow of the American College of Cardiology and a fellow of the Hong Kong College of Cardiology. In 1996, he was awarded the National May 1st Labour Medal (Model of National Work Force) and granted several Science & Technology Outstanding Contribution Awards of the Nation and Guangdong Province. He was accredited as a National Young and Middle-aged Expert with Outstanding Contributions in 1997. He was also awarded the Guangdong Province’s First Class Merit in Confronting Severe Acute Respiratory Syndrome and the National Outstanding Science and Technological Personnel in Severe Acute Respiratory Syndrome Prevention in 2003. Professor Lin has over 40 years of clinical and research experience in cardiology, especially in diagnosing cardiovascular diseases such as hypertension, hyperlipidemia, metabolic syndrome, coronary heart disease, heart failure and heart valve diseases. He published a number of academic papers at various national and overseas academic journals such as the Circulation Research, an international well-known magazine focusing on cardiovascular researches, and Chinese Medical Journal, the primary national journal, as well as monographs such as Cardiovascular Pharmacology and Clinical Pharmacology.

Xin Zhou

Professor Zhou Xin is an Independent Non-Executive Director of the Company. She holds a Doctorate Degree in Pharmaceutical Analysis from the West China School of Pharmacy, Sichuan University. She has several social positions, including a member of The Tenth and Eleventh Guizhou Committee of the Chinese People’s Political Consultative Conference an Expert Entitled to the Special Allowance of the State Council a specialist of the Guizhou Province’s Senior Technical Position Evaluation Committee for Pharmacy Professionals, a guest professor of Guangzhou Medical University and an expert of the ‘‘Service Policy Expert Institute’’ of Guizhou Province. She has been awarded with a number of honorary titles, including the Provincial Expert of Guizhou Province and the Outstanding Young Scientists of Guizhou Province. Since 2000, Professor Zhou has engaged in pharmaceutical analysis as well as the research and development of Chinese and natural medicines. She has also been in charge of a number of national technological funded projects and published a monograph of about 800,000 words and over 90 pieces of academic scientific papers. She possesses 13 representative patents.